HomeUncategorizedFDA approves treatment for episodic cluster headache

FDA approves treatment for episodic cluster headache

Author(s):

On June 4, the FDA approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults.

Read more at fda.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content